Radiotherapy, which uses high-energy radiation to kill cancer cells, typically follows a dosing and treatment plan based on clinical research to minimize the impact of the radiation on healthy tissues. However, since the ...
Jan 31, 2023
0
90
In an internationally conducted clinical trial lead by Dana-Farber involving patients with recurrent ovarian cancer that is resistant to platinum therapy, a novel conjugate therapy called mirvetuximab soravtansine resulted ...
Jan 31, 2023
0
73
Cancer irradiation with hadron beams, a method to which CERN contributed by propelling carbon ion therapy of radioresistant tumors into the medical world some thirty years ago, has treated more than 300,000 patients to date. ...
Nov 23, 2022
0
30
Scientists on Earth use high-energy protons to create isotopes to detect and treat cancer. In space, however, these same high-energy protons can pose a risk to spacecraft and the health of the astronauts traveling in them. ...
Oct 14, 2022
0
4
Molecular damage accumulates and contributes to the development of aging-related frailty and serious diseases. In some people these molecular processes are more intense than in others, a condition commonly referred to as ...
Sep 27, 2022
0
473
Many years ago, I began my Ph.D. with the firm resolve of finding a cure for cataracts—not in several years or decades, but within the duration of my Ph.D. Such was my enthusiasm and naivety. Decades later, though, that ...
Aug 26, 2022
0
35
Black adolescents who lived in poverty and were less optimistic about the future showed accelerated aging in their immune cells and were more likely to have elevated insulin resistance at ages 25-29, researchers have found.
Jul 25, 2022
0
58
The U.S. federal government spent an estimated $1.8 billion in Medicare funds in 2019 on drugs whose clinical benefits have yet to be confirmed by the Food and Drug Administration, a new study led by researchers from the ...
May 24, 2022
0
277
Vijoice (alpelisib) has been granted accelerated approval for severe PIK3CA-related overgrowth spectrum (PROS), the U.S. Food and Drug Administration announced April 6.
Apr 19, 2022
0
2
Heavy ions could radically improve radiation therapy for treatment of pancreatic cancer and other difficult-to-treat tumors if researchers can better understand how the ions work against cancer.
Apr 11, 2022
0
1
